Advertisement

Disease Severity and Staging of Obesity: a Rational Approach to Patient Selection

  • M. B. Whyte
  • S. Velusamy
  • S. J. B. AylwinEmail author
Lipid and Metabolic Effects of Gastrointestinal Surgery (F Rubino, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Lipid and Metabolic Effects of Gastrointestinal Surgery

Abstract

The increasing prevalence of obesity places ever-increasing cost demands on healthcare systems. One million individuals are eligible for bariatric surgery in the UK, and yet less than 6000 bariatric procedures are performed annually. Bariatric surgery reverses or improves almost all the medical and psychosocial co-morbidities associated with obesity. Although the BMI is a simple method to estimate adiposity at a population level, it is relatively inaccurate within an individual and provides little-to-no indication of overall health status or disease severity. Staging systems overcome the inherent limitations of BMI and allow highly informed decision-making for an individual. At a societal level, this helps to identify those most likely to gain and maximise economic benefit. This review summarises the co-morbidities associated with obesity and the evidence for their improvement following surgery. The rationale for new staging criteria and appropriate patient selection are discussed.

Keywords

Obesity Bariatric Surgery Staging 

Notes

Compliance with Ethics Guidelines

Conflict of Interest

Martin B. Whyte, S. Velusamy and Simon J. Aylwin declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Eastwood P. Statistics on obesity. England: Physical Activity and Diet; 2013.Google Scholar
  2. 2.
    Hoerger TJ, Zhang P, Segel JE, Kahn HS, Barker LE, Couper S. Cost-effectiveness of bariatric surgery for severely obese adults with diabetes. Diabetes Care. 2010;33(9):1933–9.PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr. 2000;72(3):694–701.PubMedGoogle Scholar
  4. 4.
    Krakauer NY, Krakauer JC. A new body shape index predicts mortality hazard independently of body mass index. PLoS One. 2012;7(7):e39504.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Guerrero-Romero F, Rodriguez-Moran M. Abdominal volume index. An anthropometry-based index for estimation of obesity is strongly related to impaired glucose tolerance and type 2 diabetes mellitus. Arch Med Res. 2003;34(5):428–32.PubMedCrossRefGoogle Scholar
  6. 6.
    Ciudin A, Salvador R, Budoy A, Ciudin A, Spinu C, Diaconu MG, et al. Measurement of waist circumference for retrospective studies—prospective validation of use of CT images to assess abdominal circumference. Endocrinol Nutr: Organo Soc Esp Endocrinol Nutr. 2014;61(3):147–52.CrossRefGoogle Scholar
  7. 7.
    Visscher TL, Seidell JC, Molarius A, van der Kuip D, Hofman A, Witteman JC. A comparison of body mass index, waist-hip ratio and waist circumference as predictors of all-cause mortality among the elderly: the Rotterdam study. Int J Obes Relat Metab Disord: J Int Assoc Study Obes. 2001;25(11):1730–5.CrossRefGoogle Scholar
  8. 8.
    Onat A, Hergenc G, Yuksel H, Can G, Ayhan E, Kaya Z, et al. Neck circumference as a measure of central obesity: associations with metabolic syndrome and obstructive sleep apnea syndrome beyond waist circumference. Clin Nutr. 2009;28(1):46–51.PubMedCrossRefGoogle Scholar
  9. 9.
    Carey VJ, Walters EE, Colditz GA, Solomon CG, Willett WC, Rosner BA, et al. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. Nurses’ Health Study Am J Epidemiol. 1997;145(7):614–9.CrossRefGoogle Scholar
  10. 10.
    Yang L, Samarasinghe YP, Kane P, Amiel SA, Aylwin SJ. Visceral adiposity is closely correlated with neck circumference and represents a significant indicator of insulin resistance in WHO grade III obesity. Clin Endocrinol. 2010;73(2):197–200.Google Scholar
  11. 11.
    Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow EE, et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol. 2002;39(4):578–84.PubMedCrossRefGoogle Scholar
  12. 12.
    Kalantar-Zadeh K, Streja E, Kovesdy CP, Oreopoulos A, Noori N, Jing J, et al. The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. Mayo Clin Proc. 2010;85(11):991–1001.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med. 2005;165(1):55–61.PubMedCrossRefGoogle Scholar
  14. 14.
    Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61.PubMedCrossRefGoogle Scholar
  15. 15.
    Jakobsen GS, Hofso D, Roislien J, Sandbu R, Hjelmesaeth J. Morbidly obese patients—who undergoes bariatric surgery? Obes Surg. 2010;20(8):1142–8.PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Romeo S, Maglio C, Burza MA, Pirazzi C, Sjoholm K, Jacobson P, et al. Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes. Diabetes Care. 2012;35(12):2613–7.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004;364(9435):685–96.PubMedCrossRefGoogle Scholar
  18. 18.
    Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, McMahon MM, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity. 2013;21 Suppl 1:S1–27.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Aylwin S, Al-Zaman Y. Emerging concepts in the medical and surgical treatment of obesity. Front Horm Res. 2008;36:229–59.PubMedCrossRefGoogle Scholar
  20. 20.••
    Aasheim ET, Aylwin SJB, Radhakrishnan ST, Sood AS, Jovanovic A, Olbers T, et al. Assessment of obesity beyond body mass index to determine benefit of treatment. Clin Obes. 2011;1(2–3):77–84. This paper showed how individual health domains improved after bariatric surgery and provides a rationale for use of staging criteria in selecting patients for bariatric surgery.CrossRefGoogle Scholar
  21. 21.••
    Kuk JL, Ardern CI, Church TS, Sharma AM, Padwal R, Sui X, et al. Edmonton Obesity Staging System: association with weight history and mortality risk. Appl Physiol Nutr Metab = Physiol Appliquee, Nutr Metab. 2011;36(4):570–6. Demonstrated how a scoring system could improve upon the BMI as a mortality predictor.CrossRefGoogle Scholar
  22. 22.
    Vgontzas AN, Tan TL, Bixler EO, Martin LF, Shubert D, Kales A. Sleep apnea and sleep disruption in obese patients. Arch Intern Med. 1994;154(15):1705–11.PubMedCrossRefGoogle Scholar
  23. 23.
    Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA :J Am Med Assoc. 2003;290(14):1906–14.CrossRefGoogle Scholar
  24. 24.
    Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J. 2004;25(9):735–41.PubMedCrossRefGoogle Scholar
  25. 25.
    Johns MW. Daytime sleepiness, snoring, and obstructive sleep apnea. Epworth Sleepiness Scale Chest. 1993;103(1):30–6.Google Scholar
  26. 26.
    Abrishami A, Khajehdehi A, Chung F. A systematic review of screening questionnaires for obstructive sleep apnea. J Can Anesth. 2010;57(5):423–38.CrossRefGoogle Scholar
  27. 27.
    Dixon JB, Schachter LM, O’Brien PE. Predicting sleep apnea and excessive day sleepiness in the severely obese: indicators for polysomnography. Chest. 2003;123(4):1134–41.PubMedCrossRefGoogle Scholar
  28. 28.
    AARC-APT (American Association of Respiratory Care-Association of Polysomnography Technologists). Clinical practice guideline. Polysomnography Respir Care. 1995;40(12):1336–43.Google Scholar
  29. 29.
    Gross JB, Bachenberg KL, Benumof JL, Caplan RA, Connis RT, Cote CJ, et al. Practice guidelines for the perioperative management of patients with obstructive sleep apnea: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. Anesthesiology. 2006;104(5):1081–93. quiz 117-8.PubMedCrossRefGoogle Scholar
  30. 30.
    Greenburg DL, Lettieri CJ, Eliasson AH. Effects of surgical weight loss on measures of obstructive sleep apnea: a meta-analysis. Am J Med. 2009;122(6):535–42.PubMedCrossRefGoogle Scholar
  31. 31.
    Bogers RP, Bemelmans WJ, Hoogenveen RT, Boshuizen HC, Woodward M, Knekt P, et al. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med. 2007;167(16):1720–8.PubMedCrossRefGoogle Scholar
  32. 32.
    Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67(5):968–77.PubMedCrossRefGoogle Scholar
  33. 33.
    Prospective Studies C, Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083–96.CrossRefGoogle Scholar
  34. 34.
    Williamson DF, Thompson TJ, Thun M, Flanders D, Pamuk E, Byers T. Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes care. 2000;23(10):1499–504.PubMedCrossRefGoogle Scholar
  35. 35.
    Alpert MA. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci. 2001;321(4):225–36.PubMedCrossRefGoogle Scholar
  36. 36.
    Sasson Z, Rasooly Y, Bhesania T, Rasooly I. Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation. 1993;88(4 Pt 1):1431–6.PubMedCrossRefGoogle Scholar
  37. 37.
    McCloskey CA, Ramani GV, Mathier MA, Schauer PR, Eid GM, Mattar SG, et al. Bariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2007;3(5):503–7.CrossRefGoogle Scholar
  38. 38.
    Miranda WR, Batsis JA, Sarr MG, Collazo-Clavell ML, Clark MM, Somers VK, et al. Impact of bariatric surgery on quality of life, functional capacity, and symptoms in patients with heart failure. Obes Surg. 2013;23(7):1011–5.PubMedCrossRefGoogle Scholar
  39. 39.
    Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.PubMedCrossRefGoogle Scholar
  40. 40.•
    Sjostrom L, Peltonen M, Jacobson P, Sjostrom CD, Karason K, Wedel H, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65. The Swedish Obesity Study is a landmark trial of outcomes after bariatric surgery. This paper highlights the cardiovascular benefit of bariatric surgery.PubMedCrossRefGoogle Scholar
  41. 41.
    Kwok CS, Pradhan A, Khan MA, Anderson SG, Keavney BD, Myint PK, et al. Bariatric surgery and its impact on cardiovascular disease and mortality: a systematic review and meta-analysis. Int J Cardiol. 2014;173(1):20–8.PubMedCrossRefGoogle Scholar
  42. 42.
    Look ARG, Wadden TA, West DS, Delahanty L, Jakicic J, Rejeski J, et al. The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity. 2006;14(5):737–52.CrossRefGoogle Scholar
  43. 43.
    Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE, et al. How do we define cure of diabetes? Diabetes Care. 2009;32(11):2133–5.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Brethauer SA, Aminian A, Romero-Talamas H, Batayyah E, Mackey J, Kennedy L, et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013;258(4):628–36. discussion 36-7.PubMedPubMedCentralGoogle Scholar
  45. 45.•
    Carlsson LM, Peltonen M, Ahlin S, Anveden A, Bouchard C, Carlsson B, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367(8):695–704. Showed that surgery is more effective at preventing the onset of type 2 diabetes than conventional therapy.PubMedCrossRefGoogle Scholar
  46. 46.
    Ogden J, Clementi C, Aylwin S, Patel A. Exploring the impact of obesity surgery on patients’ health status: a quantitative and qualitative study. Obes Surg. 2005;15(2):266–72.PubMedCrossRefGoogle Scholar
  47. 47.
    Brunner EJ, Marmot MG, Nanchahal K, Shipley MJ, Stansfeld SA, Juneja M, et al. Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II study. Diabetologia. 1997;40(11):1341–9.PubMedCrossRefGoogle Scholar
  48. 48.
    Karlsson J, Taft C, Ryden A, Sjostrom L, Sullivan M. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. Int J Obes. 2007;31(8):1248–61.CrossRefGoogle Scholar
  49. 49.
    Turchiano M, Saunders JK, Fernandez G, Navie L, Labrador L, Parikh M. Bariatric surgery may improve employment status in unemployed, underserved, severely obese patients. Obes Surg. 2014;24(5):692–5.PubMedCrossRefGoogle Scholar
  50. 50.
    Nicolai A, Ippoliti C, Petrelli MD. Laparoscopic adjustable gastric banding: essential role of psychological support. Obes Surg. 2002;12(6):857–63.PubMedCrossRefGoogle Scholar
  51. 51.
    Pasquali R, Patton L, Gambineri A. Obesity and infertility. Curr Opin Endocrinol Diabetes Obes. 2007;14(6):482–7.PubMedCrossRefGoogle Scholar
  52. 52.
    Hakonsen LB, Thulstrup AM, Aggerholm AS, Olsen J, Bonde JP, Andersen CY, et al. Does weight loss improve semen quality and reproductive hormones? Results from a cohort of severely obese men. Reprod Health. 2011;8:24.PubMedCrossRefPubMedCentralGoogle Scholar
  53. 53.
    Lashen H, Fear K, Sturdee DW. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod. 2004;19(7):1644–6.PubMedCrossRefGoogle Scholar
  54. 54.
    Clark AM, Thornley B, Tomlinson L, Galletley C, Norman RJ. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod. 1998;13(6):1502–5.PubMedCrossRefGoogle Scholar
  55. 55.
    Teitelman M, Grotegut CA, Williams NN, Lewis JD. The impact of bariatric surgery on menstrual patterns. Obes Surg. 2006;16(11):1457–63.PubMedCrossRefGoogle Scholar
  56. 56.
    Weintraub AY, Levy A, Levi I, Mazor M, Wiznitzer A, Sheiner E. Effect of bariatric surgery on pregnancy outcome. Int J Gynaecol Obstet:Off Organ Int Fed Gynaecol Obstet. 2008;103(3):246–51.CrossRefGoogle Scholar
  57. 57.
    Dalfra MG, Busetto L, Chilelli NC, Lapolla A. Pregnancy and foetal outcome after bariatric surgery: a review of recent studies. J Matern-fetal Neonatal Med: Off J Eur Assoc Perinatal Med, Fed Asia Oceania Perinatal Soc Int Soc Perinatal Obstet. 2012;25(9):1537–43.CrossRefGoogle Scholar
  58. 58.
    Heber D, Greenway FL, Kaplan LM, Livingston E, Salvador J, Still C, et al. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95(11):4823–43.PubMedCrossRefGoogle Scholar
  59. 59.
    Sugerman HJ. Effects of increased intra-abdominal pressure in severe obesity. Surg Clin North Am. 2001;81(5):1063–75.PubMedCrossRefGoogle Scholar
  60. 60.
    Vella VL, Jaffe W, Lidicker J, Meilahn J, Dandolu V. Prevalence of urinary symptoms in morbidly obese women and changes after bariatric surgery. J Reprod Med. 2009;54(10):597–602.PubMedGoogle Scholar
  61. 61.
    Clements RH, Gonzalez QH, Foster A, Richards WO, McDowell J, Bondora A, et al. Gastrointestinal symptoms are more intense in morbidly obese patients and are improved with laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2003;13(4):610–4.PubMedCrossRefGoogle Scholar
  62. 62.
    Sugerman HJ, Felton 3rd WL, Sismanis A, Kellum JM, DeMaria EJ, Sugerman EL. Gastric surgery for pseudotumor cerebri associated with severe obesity. Ann Surg. 1999;229(5):634–40. discussion 40-2.PubMedCrossRefPubMedCentralGoogle Scholar
  63. 63.
    Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyren O. Obesity and risk for chronic renal failure. J Am Soc Nephrol: JASN. 2006;17(6):1695–702.PubMedCrossRefGoogle Scholar
  64. 64.
    Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA: J Am Med Assoc. 2004;291(7):844–50.CrossRefGoogle Scholar
  65. 65.
    Bayliss G, Weinrauch LA, D’Elia JA. Pathophysiology of obesity-related renal dysfunction contributes to diabetic nephropathy. Curr Diabetes Rep. 2012;12(4):440–6.CrossRefGoogle Scholar
  66. 66.
    Carlsson LM, Romeo S, Jacobson P, Burza MA, Maglio C, Sjoholm K, et al. The incidence of albuminuria after bariatric surgery and usual care in Swedish obese subjects (SOS): a prospective controlled intervention trial. International Journal of Obesity. 2014.Google Scholar
  67. 67.
    Hou CC, Shyu RS, Lee WJ, Ser KH, Lee YC, Chen SC. Improved renal function 12 months after bariatric surgery. Surg Obes Relat Dis: Off J Am Soc Bariatric Surg. 2013;9(2):202–6.CrossRefGoogle Scholar
  68. 68.
    Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A. 2009;106(36):15430–5.PubMedCrossRefPubMedCentralGoogle Scholar
  69. 69.
    Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346(16):1221–31.PubMedCrossRefGoogle Scholar
  70. 70.
    Kozakova M, Palombo C, Eng MP, Dekker J, Flyvbjerg A, Mitrakou A, et al. Fatty liver index, gamma-glutamyltransferase, and early carotid plaques. Hepatology. 2012;55(5):1406–15.PubMedCrossRefGoogle Scholar
  71. 71.
    Mummadi RR, Kasturi KS, Chennareddygari S, Sood GK. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc. 2008;6(12):1396–402.CrossRefGoogle Scholar
  72. 72.•
    Padwal RS, Pajewski NM, Allison DB, Sharma AM. Using the Edmonton Obesity Staging System to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ : Can Med Assoc J = J’Assoc Med Canad. 2011;183(14):E1059–66. This paper showed that the presence of a severe complication affects survival in all grades of obesity. This highlights the importance of obesity staging.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of NutritionUniversity of SurreyGuildfordUK
  2. 2.Department of EndocrinologyKing’s College Hospital NHS Foundation TrustLondonUK

Personalised recommendations